Recent trials are showing that gastrointestinal surgery may be the new cure for type 2 diabetes, but few patients have access to it.
Read More »Breastfeeding Can Prevent Diabetes Development
Study shows that breastfeeding can provide diabetes inhibiting effects for over three years.
Read More »57th EASD: Hypoglycemia Risk With A Once-weekly Basal Insulin
Insulin icodec is a novel once-weekly basal insulin analog for patients with type 2 diabetes.
Read More »Obstructive Sleep Apnea Severity and the Development of T2D
Treating obstructive sleep apnea can decrease catecholamine, increase insulin sensitivity, and decrease pancreatic beta-cell apoptosis, leading to a lower risk of developing T2D.
Read More »Benefits of Tethered Combination Therapy for Type 2 Diabetes
Tethered combination therapy for type 2 diabetes could be more beneficial than two medications taken concurrently.
Read More »Canagliflozin’s Renal and Cardiovascular Benefits in People with Heart Failure
CREDENCE trial shows that canagliflozin, an SGLT2 inhibitor, lowers the risk of cardiovascular and renal events in patients with T2DM, regardless of prior history of heart failure.
Read More »Dose Optimizing of Semaglutide for Type 2
Additional benefits are observed with dose escalation of semaglutide for patients with type 2 diabetes.
Read More »Erectile Dysfunction Found as Significant Indicator for T2D Severity
Sexual health questionnaires can be used as an early detection tool for men's CVD, coronary heart disease, stroke, and T2D.
Read More »Uncurtaining the Effect of COVID-19 In Diabetes
People with diabetes are more sensitive to increased inflammatory response, contributing to a fast spread of COVID-19 infection.
Read More »Canagliflozin Reduces Hospitalizations
Canagliflozin, an SGLT2 inhibitor, and its impact in reducing hospitalizations and health care costs in people with type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.